Hongge Liang

Chinese Academy of Medical Sciences & Peking Union Medical College

ORCID: 0000-0001-8954-2065

Publishes on Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment. 39 papers and 552 citations.

PubIndex Score93Top 7% · mid-careerHow it's scored

39Publications

552Total Citations

First publication: 2014First senior author: 2025

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies Gastric Cancer Management and Outcomes

Top publicationsby citations

<p>MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis</p>

Hongge Liang, Mengzhao Wang|OncoTargets and Therapy|2020

Cited by 111

PI3K in Cancer: Its Structure, Activation Modes and Role in Shaping Tumor Microenvironment

Xiaoyan Liu, Mengzhao Wang, Yan Xu et al.|Future Oncology|2017

Cited by 65

Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment

Hongge Liang, Mengzhao Wang, Xiaoyan Liu|OncoTargets and Therapy|2018

Cited by 55

<p>Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer</p>

Hongge Liang, Mengzhao Wang|Cancer Management and Research|2019

Cited by 51

Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers

Hongge Liang, Mengzhao Wang, Yan Xu et al.|Cancer Gene Therapy|2024

Cited by 37